In 2020, the global outbreak of CovID-19 caused a large amount of investment and research activities to develop vaccines. Many organizations are using published genomes to develop possible anti-SARS-CoV-2 vaccines. An mRNA vaccine against SARS-CoV-2, the causative virus, may show its advantages in a shorter time and become a valuable tool for disease prevention.
Relying on advanced mRNA technology and rich experience in the development of mRNA vaccines, BOC RNA can design and synthesize mRNA sequences from DNA templates and produce laboratory-scale or GMP-level mRNA vaccines to match your application from research to clinical trials.
Since the emergence of the new coronavirus (COVID-19), BOC RNA has stepped up our efforts and is committed to research and development of vaccines and treatments to contain the virus. We will continue to maintain industry cooperation to achieve the greatest chance of success.
More Information
Other COVID-19 Related Services
Liposomes Drug Delivery Services For COVID-19
Custom Oligo Synthesis Services For COVID-19 Research
COVID-19 Resources & News
| ||
Will the mRNA vaccine become the “savior” of COVID-19？ Cell Immunity: SARS-CoV-2 vaccines status bioRxiv.: Scientists Find siRNA drugs that may inhibit SARS-CoV-2 | ||
We design mRNA sequences that, when delivered into cells, produce proteins mimicking viral antigens to study immune activation and protein expression mechanisms.
Using advanced computational design, we generate optimized mRNA sequences from DNA templates for both laboratory-scale and scalable production, supporting diverse experimental objectives.
Yes, we provide services ranging from small-scale mRNA synthesis for experimental use to larger-scale production suitable for comprehensive preclinical studies.
mRNA technology eliminates the need for recombinant protein production, enabling faster design cycles, rapid testing, and iterative optimization of antigen sequences.
We implement rigorous quality control including sequence verification, integrity assessment, and comprehensive analytical characterization to guarantee optimal expression in cell models.
We provide comprehensive consultation on mRNA design, delivery strategy guidance, and one-on-one technical support to optimize experimental outcomes and ensure reproducibility.
